semaglutide news november 28 2025 Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once Drugmakers are racing to find

100m people have high cholesterol and 39m take statins a near 40% penetration rate

Semaglutide alters your food preferences and cravings, which are influenced by your taste buds, emotions, and memories

Published in Archives of Pharmacal Research (2007), this study demonstrated that the peptide stimulated hair follicle elongation at extremely low concentrations (10^-12 to 10^-9 M) and significantly increased dermal papilla cell proliferation

The animals lost the ability to regulate glucose properly, and insulin release fell apart

Retatrutide clinical trials and preliminary results Eli Lilly, the manufacturer of Retatrutide, completed their Phase II trials and released results in June 2023